A Developmental and Family-focused Approach to Management of Neonatal Abstinence Syndrome

CLICK HERE FOR ENROLLMENT FORM

COURSE DESCRIPTION: This course provides evidence-based, comprehensive instruction in the therapeutic management of Neonatal Abstinence Syndrome (NAS). Participants will learn to identify the risk factors and symptoms associated with NAS and to select appropriate outcome measures and interventions for infants with NAS while considering a family-focused approach. Course participants will have the opportunity to collaborate in small groups with one another using discussion and instructional activities designed to facilitate both learning and knowledge application.
The course is limited to (30) participants.

LEARNING OBJECTIVES:
1. Conceptualize how the rate and prevalence of drug dependent newborns in the United States impacts health care systems.
2. Develop a comprehensive approach for therapeutic examination and assessment of infants with NAS.
3. Consider the impact of drug replacement therapy on the infant’s development.
4. Identify specific evaluation tools and outcome measures across the domains of the International Classification of
Functioning which may assist with classification, clinical decision-making and intervention for infants with NAS.
5. Construct an intervention plan that comprehensively addresses the infant’s overall development integrating common family-focused considerations.

EXAMPLES OF KNOWLEDGE APPLICATION:
* Influence on clinical decisions: Provide a framework for clinical decisions from the point of diagnosis and throughout the infant/child’s clinical course.
* Practical implementation (logistical requirements, monitoring impact on clinical practice, monitoring impact on client/patient): Individuals and organizations may develop a “toolkit” of tests/measures for this patient population from diagnosis through the infant/child’s clinical course that incorporates outcome measures across the International Classification of Functioning.
* Policies/procedures: Individuals/organizations are encouraged to develop a comprehensive and standardized approach for therapy examination and developmental and family-focused intervention for infants with NAS.

COURSE DESIGN: INTERACTIVE ONLINE
The course instructors will be actively engaged with the participants during the time the course is open.
Participants may access the course materials and interactive discussion forum asynchronously (at a time that is convenient to his/her schedule) during the time the course is open. In addition to asynchronous course content (videos, reading materials, etc), (2) live online meetings are scheduled (see below for details).

CONTINUING EDUCATION UNITS:
18 contact hours (1.8 CEU)
NOTE: Participation in the online discussion forum, online meetings (if applicable) and/or completion of learning activities (if applicable) is required for continuing education credit including passing the post-course test with 70% score.
Credit for continuing education (CEU) will be provided for physical therapists/physical therapist assistants. All others are responsible for claiming education credit per their professional guideline.

COURSE SCHEDULE and ONLINE MEETINGS:
(5) Lessons are planned within the course:
Lessons 1 and 2: Sept 30- Oct 13
Lesson 3: Oct 14-Oct 27
Lessons 4 and 5: Oct 28-Nov 10

(2) online meetings are scheduled:
Week 2: Thursday, October 10, 2019, 7:30 – 8:30 pm ET
Week 4: Tuesday, November 5, 2019, 7:30 – 8:30 pm ET

REGISTRATION IS OPEN TO:
Physical Therapists, Physical Therapist Assistants, Occupational Therapists, Speech Therapists, Nurses, Physicians

CLICK HERE FOR ENROLLMENT FORM

Course Content

Lessons Status
1

CORE Orientation VIDEO

2

GENERAL COURSE INFORMATION

3

NAS FALL 2019 Small Group Introductions

4

NAS: Course Pre-Test REQUIRED

5

NAS Questions for the Presenters Discussion Forum Topic

6

NAS: Course Introduction

7

NAS Module 1: Introduction to NAS

8

NAS Module 2: Therapeutic Examination and Assessment of Infants with NAS

9

NAS ONLINE MEETING RECORDING: October 10, 2019

10

NAS Module 3: Impact of drug replacement therapy on development (Oct 14-Oct 27)

11

NAS Module 4: Evaluation Tools and Outcome Measures (Oct 28-Nov 10)

12

NAS Module 5: Intervention for infants with NAS (Oct 28-Nov 10)

« » page 1 / 2